Table 2 GO terms enriched in orthologs with same direction of fold change in both species
GO:BP terms enriched in orthologs regulated in same direction in both species | |||||
|---|---|---|---|---|---|
GO.ID | Term | Annotated | Significant | Expected | p-Value |
GO:0007218 | neuropeptide signaling pathway | 16 | 6 | 0.29 | 2.00E-07 |
GO:0055114 | oxidation-reduction process | 219 | 10 | 3.97 | 0.0056 |
GO:0006576 | cellular biogenic amine metabolism | 7 | 2 | 0.13 | 0.0064 |
GO:0006508 | proteolysis | 197 | 9 | 3.57 | 0.0086 |
GO:0046496 | nicotinamide nucleotide metabolism | 10 | 2 | 0.18 | 0.0133 |
GO:0009069 | serine family amino acid metabolism | 10 | 2 | 0.18 | 0.0133 |
GO:0019752 | carboxylic acid metabolism | 128 | 8 | 2.32 | 0.0172 |
GO:0009309 | amine biosynthetic process | 33 | 3 | 0.6 | 0.0212 |
GO:0040019 | positive regulation of embryonic development | 13 | 2 | 0.24 | 0.0222 |
GO:0008202 | steroid metabolic process | 14 | 2 | 0.25 | 0.0256 |
GO:0008033 | tRNA processing | 19 | 2 | 0.34 | 0.0455 |
GO:0006006 | glucose metabolic process | 20 | 2 | 0.36 | 0.0499 |
GO:MF terms enriched in orthologs regulated in same direction in both species | |||||
GO.ID | Term | Annotated | Significant | Expected | p-Value |
GO:0016616 | oxidoreductase activity; acting on the CH-OH group of donors, NAD or NADP as acceptor | 34 | 4 | 0.64 | 0.0034 |
GO:0016491 | oxidoreductase activity | 283 | 14 | 5.29 | 0.0107 |
GO:0016747 | transferase activity; transferring acyl groups other than amino-acyl groups | 53 | 4 | 0.99 | 0.0164 |
GO:0016831 | carboxy-lyase activity | 11 | 2 | 0.21 | 0.017 |
GO:0004175 | endopeptidase activity | 115 | 6 | 2.15 | 0.0193 |
GO:0008233 | peptidase activity | 180 | 10 | 3.37 | 0.0258 |
GO:0051287 | NAD binding | 14 | 2 | 0.26 | 0.0271 |